Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00896649 · ClinicalTrials.gov registry record · NA
Positron Emission Mammography and Standard Mammography in Women at High Risk of Breast Cancer
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 193
- Enrollment target
NCT00896649 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 193 participants.
The verdict
NCT00896649, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 193 participants
- Enrollment target
Study Summary
RATIONALE: Screening tests may help doctors find cancer cells early and plan better treatment for breast cancer. It is not yet known whether positron emission mammography is more effective than standard mammography in finding breast tumors. PURPOSE: This phase III trial is studying positron emission mammography to see how well it works compared with standard mammography in women undergoing screening mammogram at Boston Medical Center.
Interventions
- OTHER questionnaire administration
- PROCEDURE digital mammography
- PROCEDURE positron emission mammography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2009-02 |
| Est. Completion | 2017-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00896649
The ClinicalTrials.gov registry entry for NCT00896649 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 193 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which questionnaire administration is the first listed.
NCT00896649 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00896649 about?
NCT00896649 is a clinical study titled "Positron Emission Mammography and Standard Mammography in Women at High Risk of Breast Cancer". RATIONALE: Screening tests may help doctors find cancer cells early and plan better treatment for breast cancer. It is not yet known whether positron emission mammography is more effective than standard mammography in finding breast tumors. PURPOSE: This phase III trial is studying positron emissio...
What is the current status of trial NCT00896649?
This trial is currently completed. It is a NA study. The enrollment target is 193 participants. The study started on 2009-02. Estimated completion is 2017-01.
What interventions are being tested in trial NCT00896649?
The interventions under investigation include: questionnaire administration (OTHER), digital mammography (PROCEDURE), positron emission mammography (PROCEDURE).
Who is sponsoring clinical trial NCT00896649?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.